EQUITY (Details 2) - $ / shares |
9 Months Ended | 12 Months Ended |
|---|---|---|
May 31, 2021 |
Aug. 31, 2020 |
|
| Number of Options Outstanding | ||
| Number of Options Outstanding | 281,834 | |
| Number of Options Granted | 2,685,100 | |
| Number of Options Exercised | 0 | |
| Number of Options Forfeited/canceled | 0 | |
| Number of Options Outstanding | 2,966,934 | 281,834 |
| Number of Options Exercisable | 265,572 | |
| Weighted Average Exercise Price Options Outstanding | ||
| Weighted Average Exercise Price, Outstanding | $ 3.57 | |
| Weighted Average Exercise Price, Granted | 2.31 | |
| Weighted Average Exercise Price, Exercised | 0 | |
| Weighted Average Exercise Price, Forfeited/canceled | 0 | |
| Weighted Average Exercise Price, Outstanding | 2.43 | $ 3.57 |
| Weighted Average Exercise Price, Exercisable | $ 3.38 | |
| Weighted Average Remaining Contractual life, Outstanding (in years) | 9 years 6 months 25 days | 8 years 10 months 24 days |
| Weighted Average Remaining Contractual life, Granted (in years) | 10 years | |
| Weighted Average Remaining Contractual life, Exercisable (in years) | 8 years 6 months 21 days |
| X | ||||||||||
- Definition Represents period of stock option granted during period. No definition available.
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average price of options that were either forfeited or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Weighted average price at which option holders acquired shares when converting their stock options into shares. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average grant-date fair value of non-vested options outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|